SIGA Technologies Inc Total Assets
SIGA Technologies Inc total assets. Based on the latest financial reports, SIGA Technologies Inc (SIGA) holds total assets worth $219.39 Trillion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see SIGA stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of SIGA Technologies Inc (1996–2025)
Total assets of SIGA Technologies Inc from 1996 to 2025. This chart illustrates how SIGA Technologies Inc's total assets have evolved over time, based on quarterly financial data. See today's stock price for SIGA Technologies Inc for real-time trading data and today's change.
SIGA Technologies Inc - Asset Composition Analysis
SIGA Technologies Inc Total Assets Breakdown (December 2025)
SIGA Technologies Inc total assets breakdown as of December 2025. SIGA Technologies Inc's total assets of $219.39 Trillion consist of 97.0% current assets and 3.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 70.6% |
| Accounts Receivable | $3.26 Million | 1.5% |
| Inventory | $49.05 Million | 22.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $898.33K | 0.4% |
Asset Composition Trend (1996–2025)
This chart illustrates how SIGA Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is SIGA Technologies Inc's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SIGA Technologies Inc's current assets represent 97.0% of total assets in 2025, an increase from 83.3% in 1996.
- Cash Position: Cash and equivalents constituted 70.6% of total assets in 2025, up from 0.0% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1996.
- Asset Diversification: The largest asset category is inventory at 22.4% of total assets.
SIGA Technologies Inc Competitors by Total Assets
Key competitors of SIGA Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Viatris Inc
NASDAQ:VTRS
|
USA | $35.04 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE
|
India | Rs96.12 Billion |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
USA | $3.01 Million |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
|
Curaleaf Holdings Inc.
TO:CURA
|
Canada | CA$2.88 Billion |
|
Cansino Biologics Inc
SHG:688185
|
China | CN¥7.18 Billion |
SIGA Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.25 | 8.40 | 15.94 |
| Quick Ratio | 2.38 | 6.28 | 13.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $146.37 Trillion | $205.82 Million | $119.10 Million |
SIGA Technologies Inc - Advanced Valuation Insights
This section examines the relationship between SIGA Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.67 |
| Latest Market Cap to Assets Ratio | 0.99 |
| Asset Growth Rate (YoY) | -10.2% |
| Total Assets | $219.47 Million |
| Market Capitalization | $218.04 Million USD |
Valuation Analysis
Near Book Valuation: The market values SIGA Technologies Inc's assets close to their book value (0.99x), suggesting investors view the company's assets at approximately fair value.
Significant Asset Reduction: SIGA Technologies Inc's assets decreased by 10.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for SIGA Technologies Inc (1996–2025)
The table below shows the annual total assets of SIGA Technologies Inc from 1996 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $219.47 Million | -10.18% |
| 2024-12-31 | $244.34 Million | -3.94% |
| 2023-12-31 | $254.35 Million | +30.41% |
| 2022-12-31 | $195.04 Million | -9.17% |
| 2021-12-31 | $214.73 Million | +43.31% |
| 2020-12-31 | $149.83 Million | -24.54% |
| 2019-12-31 | $198.57 Million | -2.40% |
| 2018-12-31 | $203.44 Million | +40.63% |
| 2017-12-31 | $144.67 Million | -10.13% |
| 2016-12-31 | $160.98 Million | -13.33% |
| 2015-12-31 | $185.73 Million | +11.63% |
| 2014-12-31 | $166.39 Million | -14.16% |
| 2013-12-31 | $193.82 Million | +83.14% |
| 2012-12-31 | $105.84 Million | +17.10% |
| 2011-12-31 | $90.38 Million | +234.35% |
| 2010-12-31 | $27.03 Million | +4.31% |
| 2009-12-31 | $25.92 Million | +194.58% |
| 2008-12-31 | $8.80 Million | -16.92% |
| 2007-12-31 | $10.59 Million | -24.52% |
| 2006-12-31 | $14.03 Million | +129.77% |
| 2005-12-31 | $6.11 Million | -0.09% |
| 2004-12-31 | $6.11 Million | +0.18% |
| 2003-12-31 | $6.10 Million | +115.53% |
| 2002-12-31 | $2.83 Million | -32.74% |
| 2001-12-31 | $4.21 Million | +31.07% |
| 2000-12-31 | $3.21 Million | -5.58% |
| 1999-12-31 | $3.40 Million | -52.11% |
| 1998-12-31 | $7.10 Million | -36.04% |
| 1997-12-31 | $11.10 Million | +1750.00% |
| 1996-12-31 | $600.00K | -- |
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.